Cargando…
Pure red cell aplasia due to antibody against erythropoietin in hemodialysis patients
BACKGROUND: Anemia is a common complication of chronic renal failure due to reduce erythropoietin production by kidneys. Anemia treated with recombinant human erythropoietin (rHu-EPO). Pure red cell aplasia (PRCA) due to antibody productionagainst rHu-EPO is a rare but major complication of this dru...
Autores principales: | Rahbar, Maryam, Chitsazian, Zahra, Abdoli, Firoozeh, Moeini Taba, Seyed-Masoud, Akbari, Hosein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Diabetic Nephropathy Prevention
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106879/ https://www.ncbi.nlm.nih.gov/pubmed/28042550 http://dx.doi.org/10.15171/jnp.2017.05 |
Ejemplares similares
-
Erythropoietin‐induced pure red cell aplasia
por: Yeung, Vivian K. P.
Publicado: (2022) -
Acquired Pure Red Cell Aplasia and Recombinant Erythropoietin
por: Padhi, Somanath, et al.
Publicado: (2021) -
Roxadustat in the treatment of a hemodialysis patient with anti-erythropoietin antibody-mediated pure red cell aplasia
por: Xu, Bojun, et al.
Publicado: (2021) -
Pure red cell aplasia and anti-erythropoietin antibodies in patients on hemodialysis: a report of two cases and a literature review
por: Lacreta, Gabriela, et al.
Publicado: (2018) -
Anti-Erythropoietin Antibody Associated Pure Red Cell Aplasia Resolved after Liver Transplantation
por: Hung, Annie K., et al.
Publicado: (2015)